The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AGY ALLERGY THERAPEUTICS PLC ORD 0.1P



Income Statement  (£ m) 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Continuing Operations
Revenue  40.75 41.55 41.28 39.28 41.96
Operating Profit/(Loss)  1.46 0.12 1.09 0.67 1.21
Net Interest  1.60 1.34 1.46 0.21 0.10
Profit Before Tax  -0.12 -2.31 0.64 0.53 1.08
Profit After Tax  0.59 -2.66 0.82 0.63 0.74
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  0.59 -2.66 0.82 0.63 0.74
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  0.59 -2.66 0.82 0.63 0.74
 
Continuing EPS
Earnings per Share - Basic  0.20p -0.86p 0.25p 0.14p 0.16p
Earnings per Share - Diluted  0.19p -0.86p 0.24p 0.13p 0.16p
Earnings per Share - Adjusted  0.20p -0.86p 0.25p 0.14p 0.16p
Continuing and Discontinued EPS
Earnings per Share - Basic  0.20p -0.86p 0.25p 0.14p 0.16p
Earnings per Share - Diluted  0.19p -0.86p 0.24p 0.13p 0.16p
Earnings per Share - Adjusted  0.20p -0.86p 0.25p 0.14p 0.16p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Assets
Non-Current Assets
Property, Plant & Equipment  5.89 8.81 7.56 7.34 7.03
Intangible Assets  3.36 4.41 4.60 3.91 3.77
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  2.02 2.49 2.57 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  3.05 0.00 0.00 3.26 3.39
  14.31 15.71 14.72 14.51 14.19
Current Assets
Inventories  6.89 7.09 6.65 6.01 6.47
Trade & Other Receivables  3.39 6.78 5.00 7.19 5.37
Cash at Bank & in Hand  4.52 1.05 0.90 1.26 2.03
Current Asset Investments  0.00 0.00 0.48 0.00 0.35
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  14.80 14.91 13.03 14.46 14.21
 
Total Assets  29.12 30.62 27.75 28.96 28.40
 
Liabilities
Current Liabilities
Borrowings  -1.11 -2.79 -1.43 -0.29 -0.05
Other Current Liabilities  -8.88 -8.35 -6.32 -7.33 -6.43
  -9.98 -11.15 -7.75 -7.62 -6.47
 
Net Current Assets  4.82 3.77 5.29 6.84 7.74
 
Non-Current Liabilities
Borrowings  -10.60 -12.36 -0.10 0.00 0.00
Provisions  -0.25 -0.48 -0.44 -0.46 -0.36
Other Non-Current Liabilities  -4.40 -4.49 -4.88 -6.21 -6.49
  -15.25 -17.34 -5.42 -6.67 -6.85
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -25.23 -28.48 -13.16 -14.29 -13.32
 
Net Assets  3.89 2.14 14.59 14.67 15.08
 
Capital & Reserves
Share Capital  0.32 0.32 0.42 0.42 0.42
Share Premium Account  58.70 58.71 67.57 67.72 67.72
Other Reserves  42.84 43.40 46.73 45.87 45.47
Retained Earnings  -97.98 -100.29 -100.13 -99.34 -98.53
Shareholders Funds  3.89 2.14 14.59 14.67 15.08
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  3.89 2.14 14.59 14.67 15.08

Ratios - based on IFRS 30-Jun-10 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14
Continuing Operations
PE Ratio - Adjusted  57.50 -16.28 31.00 70.54 93.75
PEG - Adjusted  n/a n/a n/a -1.60 6.56
Earnings per Share Growth - Adjusted  n/a n/a n/a -44.00% 14.29%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  13.90p 13.37p 12.63p 8.67p 9.29p
Pre-Tax Profit per Share  -0.04p -0.74p 0.20p 0.12p 0.24p
Operating Margin  3.61% -2.34% 5.07% 1.60% 2.58%
Return on Capital Employed  9.21% -5.55% 12.58% 4.18% 6.54%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  0.17p -0.73p 2.46p 2.63p 2.76p
Net Gearing  184.89% 659.47% 4.25% -6.60% -13.13%

Data is provided by Morningstar

Market

Company Information
Updated Monthly
Company address Dominion Way, Worthing, BN14 8SA, United Kingdom
Company website http://www.allergythera...
Market cap(in millions)* £ 128.27
Listing/Admission to trading 11 Oct 2004
Trading service -
Market -
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-Jul-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



ALLERGY THERA. share - fundamentals